DatasetName,MTX3_S(15) MTX3_S(188) MTX3_S(223) MTX3_S(244) MTX3_S(249) MTX3_S(250) MTX3_S(284) MTX3_S(296) MTX3_S(298) MTX3_S(306) MTX3_S(311) MTX3_S(8) MTX3_T(237) MTX3_T(298),MTX3_T(456)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,
FSO2013_Ratio M/L normalized Rep3,0.4948809977438552,
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,,
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,0.49883504976908133,
RKK2015_TNF-α/basal,,
JJ2018_Ratio H/M normalized pP2,0.5148516618059629,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,
ZX2022_Control Replicate 2,,
HS2024_6_B_T3,,
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,0.5017896368177152,
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,0.5062867644880099,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,,
DB2022_Intensity L2,0.5059143598868491,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,,
FSO2013_Ratio M/L normalized Rep1___1,0.501839360813042,
SAS2015_AZD/DMSO_Exp3,,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,
RB2022_5_PreEndurance,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,0.4980089296477766,
WZ2023_Pu_010_30min,,
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,0.5124672542028489,
RB2022_8_RecoveryEndurance,0.5073332550766555,
KBE2022_Log2_Ex_14_U,0.5104101120126789,
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,0.5159620169370247,
JJ2018_Ratio H/L normalized___1,0.5133340439898506,
ZQ2022_C2,,
RB2022_5_PreSprint,,
PG2020_Intensity 8h_C,0.48790109784188523,
AH2018_SILAC_MR_2_N,0.5134506161175516,
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,0.512807277406481,
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,
UK2020_HCM_2,0.4892213625580384,
FSO2013_Ratio H/L normalized Rep2___2,,
EP2017_Pervanadate R#3 normalized log2 ratio,0.4995704563799519,
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,0.5089424917921186,
GF2025_P6_Sph,0.5053175678639038,
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,,
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,,
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,,
KBE2022_Log2_Ex_34_U,,
WZ2023_Pu_005_10min,,
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,
WZ2023_Pu_025_30min,,
AH2018_SILAC_MR_2_X,0.5127370830133716,
HS2024_4_PD_T2,,
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,0.4999026713956574,
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,,
EJN2021_3_Rest_Basal,0.5024424677537515,
CR2017_Ratio Replicate 1.3,0.5006356304274165,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,0.5052941363102132,
JJ2018_Ratio M/L normalized pP3,0.5104809006027339,
AH2018_SILAC_M_2_N,0.5071290530623258,
HS2024_7_PD_T2,,
FSO2013_Ratio H/L normalized Rep1___1,0.48696977148278237,
AH2018_LFQ_1_C,0.5102031528697626,
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,,
HS2024_3_B_N1,,
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,,
CK2022_11 40-1,,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,0.5067138136554782,
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,0.5077209259509691,
FSO2013_Ratio H/L normalized Rep2,0.5147277342165618,
WZ2023_Pu_005_20min,,
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,0.4961465871781913,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,0.5117259569131768,
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,
HS2024_9_B_T2,,
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,,
FSO2013_Ratio M/L normalized Rep3___2,,
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,,
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,0.5041519849791846,
HS2024_4_B_N1,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,,
CK2022_1 200-1,0.5026637233180067,
PG2020_Intensity Mock_10h_D,,
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,0.4959453506544034,
RB2022_6_RecoveryEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,0.512256616772577,
RCJD2014_5min_1,,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,,
CR2017_Ratio Replicate 3.3,0.5082364982704279,
PG2020_Intensity 2h_C,,
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,,
KBE2022_Log2_Ex_8_T,0.5087829681887913,
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,,
RN2012_L11,,
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,
HS2024_5_PD_T1,,
AH2018_LFQ_M_2_C,0.5133233138808493,
CK2022_3 40-1,,
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,,
YA2020_Reporter_intensity_Cancer_No.5,0.5024505839330807,
HH2022_Reporter intensity 8,,
ZQ2022_N2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,0.5090818660255579,
EJN2021_5_Rest_Basal,0.5044689106205453,
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,0.5216300561339005,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,0.5062679323255731,
YA2020_Reporter_intensity_Normal_No.1,0.5118806806264155,
HS2024_3_B_T1,,
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,
RB2022_1_PostEndurance,,
CR2017_Ratio Replicate 3,0.4958801700875789,
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,0.5147225396620797,
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,0.5084452961849698,
HS2024_8_I_T3,,
CF2017_EOC 3,0.5009023364454543,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,,
DL2023_12h-2,,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,,
AS2011_Ratio H/L_3,,
CK2022_1 40-1,,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,,
KS2014_Intensity N3,0.5212031541024225,
RB2022_4_RecoveryEndurance,,
RB2022_5_RecoveryEndurance,,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,0.500467838746686,
FSO2013_Ratio H/M normalized Rep2,0.5122080564812261,
RAM2015_Log2 A,0.5004224603266966,
HS2024_8_PD_T1,,
JJ2018_Ratio H/L normalized pP2,0.503307049066031,
CF2017_OSE 27,0.5081320788798208,
KS2014_Intensity E15_2,0.5037900909754318,
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,,
HS2024_7_I_T1,,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,,
AH2018_SILAC_M_3_X,0.5054456348057605,
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,,
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,0.5116604374868584,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,,
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,0.4992460376596725,
HS2024_6_B_N1,,
KBE2022_Log2_Ex_27_T,0.507261865150565,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),0.5180701426115691,
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,0.5080406010342441,
AH2018_SILAC_IT_3_X,0.5087926121313878,
JAW2011_Ratio H/L,0.49152930353552465,
PG2020_Intensity 10h_C,0.4909772953583211,
FSO2013_Ratio M/L normalized Rep2,0.4945975375687088,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,0.4977076206202303,
SR2019_HCC1954_Biol_repl_2,,
CK2022_14 40-1,,
RB2022_6_PreSprint,,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,0.49161437983888717,
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,0.5110198021693255,
DL2023_control-1,,
AR2021_ALG 10 μM,0.4986816355581298,
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,0.5084842222829714,
EJN2021_4_Rest_Ins,0.5074569674614007,
RN2012_H05,,
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,0.5056880603118079,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,
EJN2021_1_Rest_Ins,0.5055756415966718,
HH2022_Reporter intensity 3,0.5078228754653058,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,0.49832242023237167,
JW2021_After_3,,
GF2025_P8_Sph,0.5076647395912098,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,0.49576931528857354,
AH2018_SILAC_2_N,0.5069252830743066,
CK2022_11 200-1,0.5028136714099313,
CK2022_12 200-1,0.5020141625462707,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,0.5057472970476681,
WZ2023_Su_010_20min,,
AH2018_TMTMS2_2_N,0.5173518246705185,
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),0.5183694933068176,
AH2018_TMTMS3_Pool,0.5089189308527998,
KS2014_Intensity N4,0.5236778769771557,
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,0.5105859600634649,
CK2022_14 200-1,0.50130990079831,
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,,
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,0.5071288198308949,
AST2020_anti-CD3+PDL2.2,,
PG2020_Intensity Mock_10h_A,,
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,0.5061890242177394,
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,,
GF2025_P1_Adh,0.5059658040263498,
GF2025_P1_Sph,0.4919455375411436,
EJN2021_5_Ex_Basal,0.5043919709135817,
HS2024_7_I_T3,,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,,
CF2017_EOC 1,0.5018282720997977,
CK2022_3 200-1,0.5031501688553969,
AH2018_LFQ_IT_3_C,0.5061090403174352,
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),,
RB2022_3_RecoverySprint,,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,,
HS2024_5_B_T1,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,,
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,,
RB2022_6_PreStrength,,
CK2022_2 40-1,,
RB2022_1_PostSprint,,
CK2022_4 200-1,0.5025785045972105,
JW2021_Before_2,,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,,
AR2021_ALG 1 μM,0.5139134912626319,
HS2024_4_B_T1,,
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,0.5033836460784797,
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,,
CR2017_Ratio Replicate 3.2,0.5082988895225673,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,0.5089474812992606,
CK2022_9 16-1,,
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,0.5014108576576908,
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,0.4984630743228045,
CK2022_16 16-1,,
FS2019_db/db3,,
CK2022_15 40-1,,
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,,
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),0.5152970866523156,
KBE2022_Log2_Ex_41_T,,
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,0.5066810049499575,
HS2024_5_PD_T3,,
AH2018_TMTMS3_3_X,0.5110657889819049,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,0.5108998308426334,
AH2018_LFQ_M_1_N,0.511942628740176,
KBE2022_Log2_Ex_27_U,0.5079435999025045,
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,
AH2018_SILAC_M_1_N,0.5040708237263479,
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,0.5055352457852155,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,,
YA2020_Reporter_intensity_Normal_No.4,0.5100658366072489,
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,,
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,,
RN2012_L13,,
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,0.509255071438812,
SR2019_SKBR3_Biol_repl_3,,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,0.5127982383292163,
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,,
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,0.4943224590035671,
HH2022_Reporter intensity 6,0.5054785295385521,
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,0.49942668702634113,
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,
AH2018_TMTMS2_3_X,0.5195036856189386,
GF2025_P3_Adh,0.5249845070818863,
SR2019_JIMT1_Biol_repl_2,,
AH2018_TMTMS2_1_C,0.5143413954659638,
RM2024_Intensity D0-1___2,,
LY2019_P4+,0.517161374898878,
KBE2022_Log2_Ex_19_U,0.5126252876510314,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,,
LG2023_GSK3α-3_intensity,,
YA2020_Reporter_intensity_Cancer_No.1,0.5119149565115099,
AST2020_Control,,
JAW2011_Ratio H/L LS1a,0.4929959750160694,
RCJD2014_5min_mean,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,0.4947264089349873,
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,,
RB2022_7_RecoverySprint,,
YA2020_Reporter_intensity_Normal_No.3,0.5064035993154066,
HS2024_8_B_T2,,
AH2018_LFQ_1_X,0.5109600959176903,
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,,
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,0.5323242930716522,
HH2022_Reporter intensity 1,0.5081235478715013,
HH2022_Reporter intensity 2,0.508470936258932,
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,0.5053176717746029,
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,0.5150216538391874,
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,,
CR2017_Ratio Replicate 2,0.49547401435991834,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,0.510380268135057,
AR2021_KD 72h,0.49390182132849664,
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,0.5106190417526103,
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,0.5099106559391716,
KBE2022_Log2_Ex_9_U,0.5084476982776446,
AH2018_SILAC_M_3_N,0.5064389028052704,
KBE2022_Log2_Ex_13_T,0.5095256035262045,
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,
PG2020_Intensity Mock_10h_C,,
CF2017_OSE 29,0.5087811639108845,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,
HS2024_7_B_N2,,
PG2020_Intensity 10h_A,,
RN2012_L12,,
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,0.5045465743831793,
SAS2015_PLX/AZD_Exp1,,
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,0.5101003279924693,
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,,
RB2022_7_RecoveryEndurance,,
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,0.5082584574541007,
TM2022_S2.12h.B,,
RN2012_L15,,
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,,
FSO2013_Ratio H/M normalized Rep2___2,,
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,,
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,0.5018093258828816,
RB2022_1_PreSprint,,
HS2024_4_I_N1,,
CK2022_7 200-1,0.502482096302921,
CK2022_5 200-1,0.5025547234634743,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,0.5149038610657405,
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,0.5119144025203959,
AH2018_SILAC_MR_1_X,0.5129712911702505,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,,
AH2018_SILAC_3_C,0.5045561968832392,
EJN2021_5_Rest_Ins,0.5031708444013467,
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,0.49251327489540614,
FSO2013_Ratio H/M normalized Rep1,0.5098132678381166,
CK2022_4 16-1,,
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,0.5043885321150335,
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,0.49282450742051326,
AH2018_LFQ_1_N,,
SAS2015_PLX/DMSO_Exp1,,
SFR2015_HL_log2_ratio_avg_c,,
JJ2018_Ratio M/L normalized pP2,0.4957436743788399,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,0.4939504229164106,
FSO2013_Ratio H/L normalized Rep3,0.5221889833629328,
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,
JJ2018_Ratio M/L normalized,0.5135011809961828,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,,
KBE2022_Log2_Ex_9_T,0.5088543757916623,
AH2018_SILAC_IT_2_N,0.5026165175453856,
AH2018_SILAC_IT_1_X,0.5020521834561397,
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,,
UK2020_UA_2,0.4885691146521284,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,0.5047607147174309,
WZ2023_Pe_025_20min,,
JVO2010_Log2 Ratio M/L Normalized aphidicolin,0.493534034133885,
AH2018_LFQ_2_N,0.5125327442331182,
HS2024_4_I_N2,,
AH2018_TMTMS2_3_N,0.5183889203642932,
RN2012_H06,,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,,
WZ2023_Su_005_30min,,
SR2019_HCC1419_Biol_repl_4,,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,0.48712057000368175,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,0.49137385491230806,
WZ2023_Su_025_10min,,
AH2018_LFQ_IT_4_X,0.5052932282035715,
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,,
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,
EP2017_Pervanadate R#1 log2 ratio,0.49548845792902735,
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,0.5381856437360465,
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,,
LY2019_P7+,0.49391766601415743,
EP2017_Untreated R#1 normalized log2 ratio,0.5050835078275722,
RN2012_L10,,
PG2020_Intensity 4h_C,,
EP2017_Mitotic R#3 normalized log2 ratio,0.5132153311580241,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,0.4993759083153357,
KBE2022_Log2_Ex_24_T,,
RB2022_8_PostStrength,,
AH2018_SILAC_IT_2_X,0.5086034351900417,
HS2024_4_B_T3,,
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,,
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,0.5033137144811128,
HS2024_8_I_T2,,
KBE2022_Log2_Ex_6_U,,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,0.49027382566971456,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,0.500820146354675,
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,0.5151576493238367,
GF2025_P9_Sph,0.5152329356303085,
CK2022_6 200-1,0.5026845152991979,
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,0.5078691274734284,
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,0.48275653745279135,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,,
HS2024_4_I_T2,,
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,,
SAS2015_AZD/DMSO_Exp1,,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,,
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,
PG2020_Intensity 2h_D,,
EP2017_Untreated R#3 normalized log2 ratio,0.5085695739398555,
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,0.5026324623399713,
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,0.5091703676702305,
RB2022_7_PostEndurance,,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,0.5158011557927988,
EP2017_Pervanadate R#2 normalized log2 ratio,0.4955293351569154,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,0.5061503391529283,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,,
KBE2022_Log2_Ex_29_T,0.5096989247200595,
HS2024_7_I_T2,,
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,,
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,,
EJN2021_1_Ex_Basal,0.5048070693760695,
FR2021_Intensity.M,,
RB2022_2_PostSprint,,
AH2018_SILAC_MR_3_N,0.5129266619779544,
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,0.5067680866720177,
PG2020_Intensity CT_C,,
ZCP2016_Ratio H/L Rep 1,,
FS2019_db/db2,,
KS2014_Intensity pY_PV4,,
KBE2022_Log2_Ex_39_U,,
EP2017_Untreated R#3 log2 ratio,0.5101087218655561,
RB2022_2_PostStrength,,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,0.5105887947704308,
HS2024_8_PD_T2,,
FS2019_Ctr2,,
RB2022_6_PreEndurance,,
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,,
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,,
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,
RB2022_3_PreSprint,,
CR2017_Ratio Replicate 2.3,0.49891892580752384,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),0.5193229209514377,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,0.5093230163008352,
YA2020_Reporter_intensity_Normal_No.2,0.5019268258096975,
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,,
HS2024_3_PD_T3,,
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,0.5093465208784852,
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,0.5140122206722589,
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,0.5092745868262595,
CK2022_2 16-1,,
RAM2015_Log2 B,0.5270218784374752,
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,0.5044287408384753,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,0.493136468372847,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,,
UK2020_HCM_5,0.48935762277550404,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,,
PG2020_Intensity Mock_10h_B,,
WZ2023_Su_025_30min,,
AH2018_LFQ_4_N,0.511473582372796,
CR2017_Ratio Replicate 1.2,0.5087929201885357,
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,0.492176139832149,
HS2024_8_I_N1,,
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,0.5035440998780084,
AH2018_SILAC_M_1_X,0.5044206672260676,
RB2022_7_PreEndurance,,
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,
LY2019_P6+,0.5133683732015115,
DB2022_LFQ intensity R2,0.5043791455237527,
GF2025_P6_Adh,0.5048043875961444,
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,,
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),0.49601137088435104,
RB2022_6_PostSprint,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,0.5081687815640998,
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,,
KS2014_Intensity C5,0.5001108148650486,
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,0.5034987935176828,
RB2022_3_PostStrength,,
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,,
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,0.5129540049166432,
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,0.48044707954529536,
AH2018_LFQ_2_X,0.5114374107501977,
PG2020_Intensity 2h_B,,
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,
KS2014_Intensity E15_3,0.5093985867370677,
GF2025_P3_Sph,0.5116246167980708,
DB2022_LFQ intensity L2,0.5038063720685901,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,0.4988474975897721,
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),0.4916148063726448,
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,0.5021361031957149,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,,
JJ2018_Ratio M/L normalized pP1,0.5147091322324882,
CR2017_Ratio Replicate 2.4,0.4935619099911768,
ZQ2022_N1,,
LY2019_P6-,0.49670333895417823,
RM2024_Intensity D2-3,,
UK2020_HCM_1,0.48951405715745616,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,,
AH2018_LFQ_3_N,0.5117133223210922,
RKK2015_TNF-α/IKKb,,
SFR2015_HL_log2_ratio_std_b,,
UK2020_UA_1,0.4902583616610911,
KBE2022_Log2_Ex_13_U,0.5089508548720371,
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,0.49414953305612147,
CK2022_7 40-1,,
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,,
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,0.5045381957052181,
JJ2018_Ratio H/L normalized,0.5132528470226367,
RB2022_5_PostEndurance,,
HS2024_5_PD_T2,,
WZ2023_Su_025_20min,,
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,0.5105342556435218,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,0.4985247039393454,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,0.4853792890410843,
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,,
PG2020_Intensity 10h_D,,
RB2022_8_PreEndurance,,
HS2024_3_B_N2,,
EJN2021_4_Ex_Ins,0.5075727342941986,
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,0.5008645360241142,
EP2017_Pervanadate R#3 log2 ratio,0.5001067415826219,
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,,
RB2022_6_PostStrength,0.5131201504789605,
AH2018_SILAC_MR_3_C,0.5118826422833852,
AH2018_LFQ_M_4_C,0.5126110960272305,
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,0.5006261860588314,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,,
CK2022_6 40-1,,
DB2022_LFQ intensity R2.1,0.5046544615094349,
KBE2022_Log2_Ex_42_U,,
LY2019_P3-,0.49178005194664703,
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,0.5051539437869358,
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,,
HS2024_8_PD_T3,,
EJN2021_3_Ex_Basal,0.5050205077808159,
AST2020_Control.1,,
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,,
FS2019_Ctr3,,
WZ2023_Pu_025_20min,,
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,0.5015231703963378,
GF2025_P10_Adh,0.5179106856430585,
RB2022_1_RecoveryStrength,,
SR2019_HCC1954_Biol_repl_4,,
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,,
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,0.5161604122180267,
RB2022_4_PreSprint,,
DB2022_Intensity R2,0.5071400954941904,
AH2018_TMTMS2_Pool,0.5113292057706275,
HS2024_8_I_N2,,
RB2022_3_RecoveryStrength,0.4909323847178935,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,0.5033629350622486,
LY2019_P8+,0.520467084091232,
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,0.5147116670013352,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),0.5055493248760345,
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,0.5131757940936151,
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,,
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,0.5076292026457556,
LY2019_P2-,0.5012754688729985,
AH2018_LFQ_IT_1_X,0.5016601164322912,
JJ2018_Ratio H/L normalized pP3___1,0.49385404320445314,
RB2022_8_RecoveryStrength,0.5139089771677572,
WZ2023_Pe_005_20min,,
AST2020_Control.2,,
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,,
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,0.5241965148132677,
HS2024_3_I_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,,
SR2019_MCF10A_Biol_repl_4,,
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,0.5059353268641125,
HS2024_5_B_T2,,
HS2024_6_I_T1,,
HS2024_5_B_T3,,
JJ2018_Ratio H/M normalized pP1___1,0.5051807522449828,
KBE2022_Log2_Ex_36_U,0.5134184642361495,
AH2018_TMTMS3_3_N,0.5103128727216464,
SR2019_HCC1419_Biol_repl_2,,
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,0.511911066287608,
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,0.517727078897127,
KBE2022_Log2_Ex_36_T,0.5135303824772149,
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,,
KS2014_Intensity C2,0.5099211397269198,
FSO2013_Ratio H/L normalized Rep1___2,,
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,,
CK2022_9 200-1,0.5026767686094533,
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,0.49213377706650985,
CK2022_10 200-1,0.5020038172920724,
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,,
RBK2021_1332T Late,,
LY2019_P1-,0.5021399284854674,
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,0.5005093575307322,
HS2024_3_I_T3,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,0.5044916286757088,
ZQ2022_C3,,
EJN2021_3_Rest_Ins,0.5059011799005726,
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,,
FSO2013_Ratio H/M normalized Rep3___2,,
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,0.5061062504019503,
RKK2015_SC-514/basal,,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,,
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,,
HS2024_5_I_T3,,
KS2014_Intensity N1,0.520366891141828,
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,0.4940828900973349,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,0.49323272269410356,
AH2018_SILAC_MR_2_C,0.512128092746041,
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,,
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,0.512934966569447,
JJ2018_Ratio H/M normalized___1,0.5075936952796234,
RCJD2014_15min_2,,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,,
HS2024_5_B_N2,,
HS2024_5_I_N1,,
HS2024_6_I_N1,,
AR2021_KD 48h,0.49791199806414793,
FR2021_Intensity.B,,
RB2022_3_PreEndurance,,
HS2024_5_I_T1,,
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,,
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,,
KBE2022_Log2_Ex_29_U,0.5107614339087428,
HS2024_7_B_T1,,
AH2018_LFQ_M_2_X,0.5130692064986515,
AH2018_LFQ_IT_4_N,0.5062704011687963,
CK2022_15 200-1,0.5018227899650768,
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,0.5076621129497934,
JJ2018_Ratio M/L normalized pP3___1,0.5102666512199373,
KBE2022_Log2_Ex_34_T,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,0.5064481247614446,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,0.5032002400454346,
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,,
RN2012_H01,,
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,0.5045818680876002,
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,,
EP2017_Pervanadate R#1 normalized log2 ratio,0.49497632873048614,
HS2024_8_B_T3,,
YA2020_Reporter_intensity_Cancer_No.3,0.5007922083919597,
KBE2022_Log2_Ex_44_U,,
WZ2023_Pe_010_20min,,
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,,
RB2022_3_PreStrength,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,,
KS2014_Intensity C1,0.5102998043413002,
FSO2013_Ratio H/M normalized Rep3___1,0.5103803281608645,
AH2018_SILAC_M_3_C,0.5047118453459201,
RKK2015_TNF-α+IKKb/TNF-α,,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,0.5063336443872573,
AH2018_SILAC_M_2_X,0.5063264166545481,
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,,
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,,
PG2020_Intensity 6h_C,0.4951319828035972,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,0.510761084698135,
JJ2018_Ratio M/L normalized pP1___1,0.5146890935251671,
AH2018_LFQ_M_3_N,0.5132814155957918,
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,0.5185052577112761,
CK2022_15 16-1,,
CK2022_3 16-1,,
LY2019_P4-,0.5167827034616387,
FSO2013_Ratio H/L normalized Rep3___2,,
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,,
GF2025_P8_Adh,0.5032546916414875,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,0.5114929750516026,
CK2022_10 16-1,,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),0.4945506657707814,
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,0.4990538222476069,
DB2022_Intensity R1,0.5072253429886817,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,0.48760697274157244,
SAS2015_AZD/DMSO_Exp2,,
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,0.4969643302828236,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,0.5191458672665165,
EJN2021_2_Ex_Basal,0.5046940493724764,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),0.49837654084825755,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,0.5073896937190195,
AR2021_L41 10 μM,0.5114571779363684,
CF2017_EOC 2,0.4989902651345587,
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,0.500481749399574,
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,0.48993163858144595,
RB2022_7_PreSprint,,
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,,
CK2022_6 16-1,,
ZX2022_CB treated Replicate 1,,
BS2014_Log2(Ratio H/L normalized Rep_3),,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,0.508152186020358,
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,0.5166154075767694,
AR2021_L41 1 μM,0.500697120843895,
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,0.5166970635624318,
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,0.5019270875052233,
ZX2022_Control Replicate 3,,
KS2014_Intensity C4,0.4783812017793327,
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,0.5105133803783225,
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,,
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,
HS2024_7_B_T2,,
SAS2015_PLX/DMSO_Exp3,,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,0.5130108312573941,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,0.5077046829828867,
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,,
AH2018_SILAC_IT_3_C,0.4992293741808845,
WZ2023_Pu_025_10min,,
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,,
FSO2013_Ratio M/L normalized Rep3___1,0.49492799608038557,
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,0.49996823476335933,
JJ2018_Ratio H/L normalized pP1___1,0.5138417681583919,
WZ2023_Pe_010_30min,,
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,0.5068867363230642,
KS2014_Intensity C6,0.48961553335706576,
ZQ2022_N3,,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,,
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,,
JJ2018_Ratio H/M normalized pP1,0.5053660079263412,
CK2022_16 40-1,,
AH2018_SILAC_IT_2_C,0.5004918674209706,
CK2022_5 40-1,,
AH2018_LFQ_3_X,0.5115350690862832,
UK2020_UA_3,0.4871681123147689,
LY2019_P7-,0.4935126610481926,
GF2025_P5_Adh,0.5044272901722038,
RB2022_1_PostStrength,,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,0.5233937771960399,
SR2019_HCC1954_Biol_repl_3,,
CR2017_Ratio Replicate 2.2,0.49756092976652655,
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,,
ZQ2022_C1,,
CR2017_Ratio Replicate 2.1,0.5015545559514812,
PG2020_Intensity CT_B,,
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,0.5129665035941697,
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,0.49137753664647926,
RCJD2014_20min_3,,
AH2018_LFQ_3_C,0.5113921910707264,
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,0.5130245355843585,
YA2020_Reporter_intensity_Cancer_No.4,0.502149107165441,
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,0.5129706364429699,
RB2022_2_PreEndurance,,
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,0.5135390801595251,
FR2021_Intensity.H,,
CK2022_14 16-1,,
AST2020_anti-CD3+PDL2,,
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,0.5088574479797036,
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,,
FSO2013_Ratio H/M normalized Rep1___2,,
HS2024_8_I_T1,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,0.5162134088197042,
AH2018_TMTMS2_1_X,0.5157465461688621,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,0.5012062220645085,
HS2024_6_I_N2,,
HH2022_Reporter intensity 4,,
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,0.5049904620981077,
HS2024_4_I_T3,,
AH2018_SILAC_1_X,0.5016699674279317,
PG2020_Intensity 10h_B,,
AH2018_TMTMS3_1_X,0.5073478616840811,
CF2017_FTE 14,0.5072666360831023,
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,0.4979486758677654,
SR2019_HCC1419_Biol_repl_3,,
KBE2022_Log2_Ex_14_T,0.509204759394706,
EP2017_Untreated R#2 normalized log2 ratio,0.5135448974853671,
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,0.5006856510796536,
LY2019_P5+,0.5175364561207685,
HS2024_5_I_N2,,
SAS2015_PLX/AZD_Exp3,,
EP2017_Pervanadate R#2 log2 ratio,0.4962013046806368,
AS2011_Ratio H/L Normalized RNAi_2_1,,
